Diabetes technology & therapeutics
Real-World Incidence of Lung Malignancy and Chronic Obstructive Pulmonary Disease with Inhaled Insulin in People with Diabetes.
Kevin Cowart, Hannah Everich, Francisco Flores, Marisa Harris, Daniel Randall, Lauren Sammartano, Nicholas W Carris
Published: 202610.1177/15209156251387102
Abstract
OBJECTIVE: Inhaled insulin offers an alternative to subcutaneous administration, although concerns remain regarding pulmonary risks. We assessed the real-world safety of inhaled insulin versus rapid-acting analogue (RAA) insulin on lung malignancy an…
Preview only. Read the full abstract at the source